HIGH-INCIDENCE OF CARDIOMYOPATHY IN BETA-THALASSEMIA PATIENTS RECEIVING REGULAR TRANSFUSION AND IRON CHELATION - REVERSAL BY INTENSIFIED CHELATION

被引：1
|
作者：
ALDOURI, MA
WONKE, B
HOFFBRAND, AV
FLYNN, DM
WARD, SE
AGNEW, JE
HILSON, AJW
机构：
[1] ROYAL FREE HOSP,SCH MED,DEPT HAEMATOL,POND ST,LONDON NW3 2QG,ENGLAND
[2] WHITTINGTON HOSP,LONDON,ENGLAND
来源：
ACTA HAEMATOLOGICA | 1990年 / 84卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 117
页数：5
相关论文
共 50 条
  • [31] Iron Chelation with Deferasirox in Thalassemia Major Patients with Low Iron Burdens and Moderate to High Transfusion Regimens.
    Evans, Elizabeth
    Kleinert, Dorothy A.
    Mennitt, Kevin
    Grady, Robert W.
    Giardina, Patricia J.
    [J]. BLOOD, 2009, 114 (22) : 1562 - 1562
  • [32] The Zinc and Copper Levels in Thalassemia Major Patients, Receiving Iron Chelation Therapy
    Zekavat, Omid R.
    Bahmanjahromi, Ayda
    Haghpanah, Sezaneh
    Ebrahimi, Sara
    Cohan, Nader
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (03) : 178 - 181
  • [33] ANALYSIS OF FALL IN SERUM FERRITIN AFTER CHELATION OF IRON WITH DEFERIPRONE (L1) IN BETA-THALASSEMIA AND HEMOGLOBIN-E BETA-THALASSEMIA
    ADHIKARI, D
    ROY, TB
    CHANDRA, S
    ADHIKARI, SK
    [J]. CURRENT SCIENCE, 1995, 68 (08): : 839 - 840
  • [34] CHELATION STUDIES WITH 2,3-DIHYDROXYBENZOIC ACID IN PATIENTS WITH BETA-THALASSEMIA MAJOR
    PETERSON, CM
    GRAZIANO, JH
    GRADY, RW
    JONES, RL
    VLASSARA, HV
    CANALE, VC
    MILLER, DR
    CERAMI, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) : 477 - 485
  • [35] Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
    Romadhon, Pradana Zaky
    Ashariati, Ami
    Bintoro, Siprianus Ugroseno Yudho
    Thaha, Mochammad
    Suryantoro, Satriyo Dwi
    Windradi, Choirina
    Mahdi, Bagus Aulia
    Novendrianto, Dwiki
    Widiyastuti, Krisnina Nurul
    Martani, Okla Sekar
    Widiasi, Etha Dini
    Agustin, Esthiningrum Dewi
    Prabowo, Emil
    Putra, Yasjudan Rastrama
    Thahadian, Harik Firman
    Adhikara, Imam Manggalya
    Adyarini, Dwita Dyah
    Prahasanti, Kartika
    Putri, Aditea Etnawati
    Yusoff, Narazah Mohd
    [J]. JOURNAL OF BLOOD MEDICINE, 2022, 13 : 725 - 738
  • [36] Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia
    Jamuar, Saumya S.
    Lai, Angeline H. M.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 299 - 307
  • [37] EFFECT OF AGE AT THE START OF IRON CHELATION-THERAPY ON GONADAL-FUNCTION IN BETA-THALASSEMIA MAJOR
    BRONSPIEGELWEINTROB, N
    OLIVIERI, NF
    TYLER, B
    ANDREWS, DF
    FREEDMAN, MH
    HOLLAND, FJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (11): : 713 - 719
  • [38] CHELATION-THERAPY IN BETA-THALASSEMIA MAJOR .3. THE ROLE OF SPLENECTOMY IN ACHIEVING IRON BALANCE
    GRAZIANO, JH
    PIOMELLI, S
    HILGARTNER, M
    GIARDINA, P
    KARPATKIN, M
    ANDREW, M
    LOIACONO, N
    SEAMAN, C
    [J]. JOURNAL OF PEDIATRICS, 1981, 99 (05): : 695 - 699
  • [39] Reversal of Iron-Induced Dilated Cardiomyopathy During Therapy With Deferasirox in Beta-Thalassemia
    Trad, Omar
    Hamdan, Mohamed A.
    Jamil, Altaf
    Khanani, Muhammad F.
    Ishaqi, M. Kashif
    Shamsi, Aisha
    Hayek, Mohamed
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 52 (03) : 426 - 428
  • [40] Role of iron metabolism genetic determinants in response to chelation therapy in a cohort of beta-thalassemia and sickle cell syndromes Italian patients
    Renda, Maria Concetta
    Renda, Disma
    Piazza, Angela
    Calvaruso, Giuseppina
    Fecarotta, Emanuela
    Giangreco, Antonino
    Maggio, Aurelio
    [J]. THALASSEMIA REPORTS, 2014, 4 (02) : 28 - 31
12345